
DeiCell Systems is a regulatory and quality systems consultancy supporting pre-commercial and early-clinical biotech and medtech organizations as regulatory expectations accelerate.We design phase-appropriate GMP and QMS infrastructure that is audit-defensible without overengineering, aligned to stage, manufacturing model, and real regulatory exposure!
To learn more about how we can help:
Our systems are designed to hold up under inspection while remaining usable by small teams.
We work with:
1. Early-stage biotech companies
Scaling GMP activities under increasing regulatory scrutiny.
2. Early-stage medtech companies
Navigating quality system expectations without mature in-house leadership.
Typically pre-seed through Series B, these teams need quality infrastructure that exists now, not systems built for a future phase.


Built for Early-Stage Teams
DeiCell Systems is built for organizations where innovation velocity has outpaced internal quality structure.Our work reduces ambiguity, stabilizes execution, and prevents uncontrolled expansion of scope as regulatory pressure increases.
1. Right-Sized GMP / QMS Blueprint
• Phase-appropriate system architecture
• Defined scope boundaries and deferrals
• Practical implementation roadmap2. Gap Repair Sprints
• Targeted system stabilization
• Focused remediation of failing areas
• Clear closeout expectations3. Audit Readiness Sprints
• Readiness assessment and prioritization
• Evidence and documentation alignment
• Inspection preparation and support4. Partner Insert Support
• Bounded specialist workstreams
• Decision-ready outputs
• Defined interfaces and cadence
Site content is proprietary and may not be copied...
Registered in the State of Ohio.
© 2026 DeiCell Systems LLC. All rights reserved.
Site content is proprietary and may not be copied, reproduced, or redistributed without written permission.